The weekly litigation news digest is live. Subscribe now

IP Verse

Dexcel Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Dexcel Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Dec 4, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2994125	Efficacious Treatment Of Nsclc And Predictive Clinical Marker Of The Responsiveness Of A Tumour To A Treatment	BOEHRINGER INGELHEIM	Apr 30, 2019

Discover the latest PTAB cases involving Dexcel Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Dexcel Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DEXCEL PHARMA	1	-	-	-
BOEHRINGER INGELHEIM	49	179	10	9